ESGO Guidelines for Ovarian cancer surgery – Update

ESGO Guidelines for ovarian cancer surgery - Update - New 3 Part Webinar Series

The updated ESGO Guidelines for the Management of Ovarian Cancer will be officially introduced during the ESGO Congress 2026 in Copenhagen.

For the first time since the original 2017 surgical guidelines, ESGO is delivering a fully comprehensive, multidisciplinary update, reflecting the evolution of ovarian cancer care over the past decade.

The new recommendations will be presented across two dedicated congress sessions, structured to mirror the breadth of the guideline update and provide clinicians with practical, evidence-based guidance for modern clinical decision-making.

These sessions will offer:

  • Key updates in surgical standards

  • Integration of systemic and targeted therapies

  • Pathology and molecular considerations

  • Multidisciplinary treatment strategies

The Copenhagen Congress will mark the first public presentation of this major update.

The project is led by:

  • Dr. Ane Gerda Zahl Eriksson (Norway)

  • Prof. Anna Fagotti (Italy)

Methodological oversight is provided by François Planchamp, ESGO methodologist.

ESGO_WEBINARS_GUIDELINES_14_04_2026_BANNER_600x800

1st webinar programme

May 12th, 2026

  • Early-stage surgery – Philippe Morice
  • Early-stage adjuvant therapy – Ketta Lorusso
  • Advanced-stage surgery and HIPEC – Christina Fotopoulou
  • Advanced-stage NACT – Isabelle Ray-Coquard
  • OP report – Anna Fagotti & Ane Gerda Zahl Eriksson

2nd webinar programme

June 11th, 2026

  • Adjuvant and maintenance therapy – Christian Marth
  • Recurrent disease (platinum-sensitive) – Philipp Harter
  • Recurrent disease (non-platinum) – Jonathan Ledermann
  • Oligometastatic disease – Remi Nout
  • Diagnostic – imaging – Daniela Fischerova

3rd webinar programme

July 9h, 2026

  • Cancer care plan – Viola Heinzelmann-Schwarz
  • Diagnostics – pathology – Ben Davidson
  • Palliation – Jalid Sehouli
  • Patient perspectives – Linda Snoep

Educational Webinar Series – 2026

Following the Congress presentation, ESGO will host two dedicated educational webinars (90 minutes each) to further disseminate and discuss the updated recommendations:

  • 12 May 2026

  • 11 June 2026

  • 9 July 2026

These sessions will:

  • Expand on the Congress presentations

  • Provide in-depth exploration of key recommendations

  • Feature expert lectures

  • Include interactive discussion and Q&A

Further details regarding programme structure and speakers will be announced soon.

Who should attend the webinars

These webinars are designed for healthcare professionals involved in the management of ovarian cancer across all stages of care, including:

  • Gynecologic oncologists

  • Medical oncologists

  • Radiation oncologists

  • Pathologists

  • Fellows and trainees in gynecologic oncology

  • Surgical oncologists involved in advanced pelvic surgery

  • Multidisciplinary tumour board members

  • Clinical researchers and academic faculty

  • Oncology nurses and advanced practice providers

The sessions are particularly relevant for clinicians seeking to:

  • Update their practice according to the latest ESGO recommendations

  • Understand the integration of surgical, medical, and pathological perspectives

  • Align institutional protocols with international evidence-based standards

  • Prepare for multidisciplinary implementation of new guideline recommendations